---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-079262"
form_type: "8-K"
ticker: "CLRB"
cik: "0001279704"
company_name: "Cellectar Biosciences, Inc."
filed_at: "2024-07-11T23:59:59+00:00"
generated_at: "2026-05-31T21:43:10.898362+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cellectar Biosciences dismisses Baker Tilly, hires Deloitte; cites material weaknesses

## Summary
- Audit Committee dismissed Baker Tilly and is engaging Deloitte & Touche as independent auditor for FY2024, subject to standard procedures.
- Baker Tilly's prior reports contained a going-concern emphasis paragraph; no disagreements except disclosed material weaknesses.
- Material weaknesses identified: fair value methodologies for Level 3 instruments, stock-based compensation controls, and segregation of duties/user access.
- No prior consultations with Deloitte on accounting principles or disagreements during fiscal years 2022-2023 and interim 2024.

## SEC filing metadata
- accession: 0001104659-24-079262
- form_type: 8-K
- ticker: CLRB
- cik: 0001279704
- company_name: Cellectar Biosciences, Inc.
- filed_at: 2024-07-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1279704/000110465924079262/0001104659-24-079262-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1279704/000110465924079262/tm2419333d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-079262
- JSON: https://secwatch.observer/filing/0001104659-24-079262.json
- Plain text: https://secwatch.observer/filing/0001104659-24-079262.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.